Global Rabies Virus Monoclonal Antibody Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Rabies virus monoclonal antibodies are laboratory-made antibodies designed to target and neutralize the rabies virus.These monoclonal antibodies are highly specific,meaning they can effectively bind to the virus and prevent it from entering host cells.They are used as part of post-exposure prophylaxis to provide immediate,targeted protection and are often combined with the rabies vaccine.
The global Rabies Virus Monoclonal Antibody market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Rabies Virus Monoclonal Antibody Industry Forecast” looks at past sales and reviews total world Rabies Virus Monoclonal Antibody sales in 2023, providing a comprehensive analysis by region and market sector of projected Rabies Virus Monoclonal Antibody sales for 2024 through 2030. With Rabies Virus Monoclonal Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rabies Virus Monoclonal Antibody industry.
This Insight Report provides a comprehensive analysis of the global Rabies Virus Monoclonal Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rabies Virus Monoclonal Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rabies Virus Monoclonal Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rabies Virus Monoclonal Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rabies Virus Monoclonal Antibody.
United States market for Rabies Virus Monoclonal Antibody is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Rabies Virus Monoclonal Antibody is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Rabies Virus Monoclonal Antibody is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Rabies Virus Monoclonal Antibody players cover Serum Institute of India, Zydus Lifesciences, North China Pharmaceutical, Xingmeng Biopharmaceuticals (Suzhou), etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Rabies Virus Monoclonal Antibody market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Rabies Virus Monoclonal Antibody market?
What factors are driving Rabies Virus Monoclonal Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rabies Virus Monoclonal Antibody market opportunities vary by end market size?
How does Rabies Virus Monoclonal Antibody break out by Type, by Application?
Rabies virus monoclonal antibodies are laboratory-made antibodies designed to target and neutralize the rabies virus.These monoclonal antibodies are highly specific,meaning they can effectively bind to the virus and prevent it from entering host cells.They are used as part of post-exposure prophylaxis to provide immediate,targeted protection and are often combined with the rabies vaccine.
The global Rabies Virus Monoclonal Antibody market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Rabies Virus Monoclonal Antibody Industry Forecast” looks at past sales and reviews total world Rabies Virus Monoclonal Antibody sales in 2023, providing a comprehensive analysis by region and market sector of projected Rabies Virus Monoclonal Antibody sales for 2024 through 2030. With Rabies Virus Monoclonal Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rabies Virus Monoclonal Antibody industry.
This Insight Report provides a comprehensive analysis of the global Rabies Virus Monoclonal Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rabies Virus Monoclonal Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rabies Virus Monoclonal Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rabies Virus Monoclonal Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rabies Virus Monoclonal Antibody.
United States market for Rabies Virus Monoclonal Antibody is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Rabies Virus Monoclonal Antibody is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Rabies Virus Monoclonal Antibody is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Rabies Virus Monoclonal Antibody players cover Serum Institute of India, Zydus Lifesciences, North China Pharmaceutical, Xingmeng Biopharmaceuticals (Suzhou), etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Rabies Virus Monoclonal Antibody market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 100IU per Vial
- 200IU per Vial
- 250IU per Vial
- 600IU per Vial
- 1500IU per Vial
- Category II Exposure
- Category III Exposure
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Serum Institute of India
- Zydus Lifesciences
- North China Pharmaceutical
- Xingmeng Biopharmaceuticals (Suzhou)
What is the 10-year outlook for the global Rabies Virus Monoclonal Antibody market?
What factors are driving Rabies Virus Monoclonal Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rabies Virus Monoclonal Antibody market opportunities vary by end market size?
How does Rabies Virus Monoclonal Antibody break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rabies Virus Monoclonal Antibody Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Rabies Virus Monoclonal Antibody by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Rabies Virus Monoclonal Antibody by Country/Region, 2019, 2023 & 2030
2.2 Rabies Virus Monoclonal Antibody Segment by Type
2.2.1 100IU per Vial
2.2.2 200IU per Vial
2.2.3 250IU per Vial
2.2.4 600IU per Vial
2.2.5 1500IU per Vial
2.3 Rabies Virus Monoclonal Antibody Sales by Type
2.3.1 Global Rabies Virus Monoclonal Antibody Sales Market Share by Type (2019-2024)
2.3.2 Global Rabies Virus Monoclonal Antibody Revenue and Market Share by Type (2019-2024)
2.3.3 Global Rabies Virus Monoclonal Antibody Sale Price by Type (2019-2024)
2.4 Rabies Virus Monoclonal Antibody Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Rabies Virus Monoclonal Antibody Sales by Application
2.5.1 Global Rabies Virus Monoclonal Antibody Sale Market Share by Application (2019-2024)
2.5.2 Global Rabies Virus Monoclonal Antibody Revenue and Market Share by Application (2019-2024)
2.5.3 Global Rabies Virus Monoclonal Antibody Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Rabies Virus Monoclonal Antibody Breakdown Data by Company
3.1.1 Global Rabies Virus Monoclonal Antibody Annual Sales by Company (2019-2024)
3.1.2 Global Rabies Virus Monoclonal Antibody Sales Market Share by Company (2019-2024)
3.2 Global Rabies Virus Monoclonal Antibody Annual Revenue by Company (2019-2024)
3.2.1 Global Rabies Virus Monoclonal Antibody Revenue by Company (2019-2024)
3.2.2 Global Rabies Virus Monoclonal Antibody Revenue Market Share by Company (2019-2024)
3.3 Global Rabies Virus Monoclonal Antibody Sale Price by Company
3.4 Key Manufacturers Rabies Virus Monoclonal Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rabies Virus Monoclonal Antibody Product Location Distribution
3.4.2 Players Rabies Virus Monoclonal Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RABIES VIRUS MONOCLONAL ANTIBODY BY GEOGRAPHIC REGION
4.1 World Historic Rabies Virus Monoclonal Antibody Market Size by Geographic Region (2019-2024)
4.1.1 Global Rabies Virus Monoclonal Antibody Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Rabies Virus Monoclonal Antibody Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Rabies Virus Monoclonal Antibody Market Size by Country/Region (2019-2024)
4.2.1 Global Rabies Virus Monoclonal Antibody Annual Sales by Country/Region (2019-2024)
4.2.2 Global Rabies Virus Monoclonal Antibody Annual Revenue by Country/Region (2019-2024)
4.3 Americas Rabies Virus Monoclonal Antibody Sales Growth
4.4 APAC Rabies Virus Monoclonal Antibody Sales Growth
4.5 Europe Rabies Virus Monoclonal Antibody Sales Growth
4.6 Middle East & Africa Rabies Virus Monoclonal Antibody Sales Growth
5 AMERICAS
5.1 Americas Rabies Virus Monoclonal Antibody Sales by Country
5.1.1 Americas Rabies Virus Monoclonal Antibody Sales by Country (2019-2024)
5.1.2 Americas Rabies Virus Monoclonal Antibody Revenue by Country (2019-2024)
5.2 Americas Rabies Virus Monoclonal Antibody Sales by Type (2019-2024)
5.3 Americas Rabies Virus Monoclonal Antibody Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rabies Virus Monoclonal Antibody Sales by Region
6.1.1 APAC Rabies Virus Monoclonal Antibody Sales by Region (2019-2024)
6.1.2 APAC Rabies Virus Monoclonal Antibody Revenue by Region (2019-2024)
6.2 APAC Rabies Virus Monoclonal Antibody Sales by Type (2019-2024)
6.3 APAC Rabies Virus Monoclonal Antibody Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rabies Virus Monoclonal Antibody by Country
7.1.1 Europe Rabies Virus Monoclonal Antibody Sales by Country (2019-2024)
7.1.2 Europe Rabies Virus Monoclonal Antibody Revenue by Country (2019-2024)
7.2 Europe Rabies Virus Monoclonal Antibody Sales by Type (2019-2024)
7.3 Europe Rabies Virus Monoclonal Antibody Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rabies Virus Monoclonal Antibody by Country
8.1.1 Middle East & Africa Rabies Virus Monoclonal Antibody Sales by Country (2019-2024)
8.1.2 Middle East & Africa Rabies Virus Monoclonal Antibody Revenue by Country (2019-2024)
8.2 Middle East & Africa Rabies Virus Monoclonal Antibody Sales by Type (2019-2024)
8.3 Middle East & Africa Rabies Virus Monoclonal Antibody Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rabies Virus Monoclonal Antibody
10.3 Manufacturing Process Analysis of Rabies Virus Monoclonal Antibody
10.4 Industry Chain Structure of Rabies Virus Monoclonal Antibody
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rabies Virus Monoclonal Antibody Distributors
11.3 Rabies Virus Monoclonal Antibody Customer
12 WORLD FORECAST REVIEW FOR RABIES VIRUS MONOCLONAL ANTIBODY BY GEOGRAPHIC REGION
12.1 Global Rabies Virus Monoclonal Antibody Market Size Forecast by Region
12.1.1 Global Rabies Virus Monoclonal Antibody Forecast by Region (2025-2030)
12.1.2 Global Rabies Virus Monoclonal Antibody Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Rabies Virus Monoclonal Antibody Forecast by Type (2025-2030)
12.7 Global Rabies Virus Monoclonal Antibody Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Serum Institute of India
13.1.1 Serum Institute of India Company Information
13.1.2 Serum Institute of India Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
13.1.3 Serum Institute of India Rabies Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Serum Institute of India Main Business Overview
13.1.5 Serum Institute of India Latest Developments
13.2 Zydus Lifesciences
13.2.1 Zydus Lifesciences Company Information
13.2.2 Zydus Lifesciences Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
13.2.3 Zydus Lifesciences Rabies Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Zydus Lifesciences Main Business Overview
13.2.5 Zydus Lifesciences Latest Developments
13.3 North China Pharmaceutical
13.3.1 North China Pharmaceutical Company Information
13.3.2 North China Pharmaceutical Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
13.3.3 North China Pharmaceutical Rabies Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 North China Pharmaceutical Main Business Overview
13.3.5 North China Pharmaceutical Latest Developments
13.4 Xingmeng Biopharmaceuticals (Suzhou)
13.4.1 Xingmeng Biopharmaceuticals (Suzhou) Company Information
13.4.2 Xingmeng Biopharmaceuticals (Suzhou) Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
13.4.3 Xingmeng Biopharmaceuticals (Suzhou) Rabies Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Xingmeng Biopharmaceuticals (Suzhou) Main Business Overview
13.4.5 Xingmeng Biopharmaceuticals (Suzhou) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Rabies Virus Monoclonal Antibody Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Rabies Virus Monoclonal Antibody Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 100IU per Vial
Table 4. Major Players of 200IU per Vial
Table 5. Major Players of 250IU per Vial
Table 6. Major Players of 600IU per Vial
Table 7. Major Players of 1500IU per Vial
Table 8. Global Rabies Virus Monoclonal Antibody Sales byType (2019-2024) & (K Units)
Table 9. Global Rabies Virus Monoclonal Antibody Sales Market Share byType (2019-2024)
Table 10. Global Rabies Virus Monoclonal Antibody Revenue byType (2019-2024) & ($ million)
Table 11. Global Rabies Virus Monoclonal Antibody Revenue Market Share byType (2019-2024)
Table 12. Global Rabies Virus Monoclonal Antibody Sale Price byType (2019-2024) & (US$/Unit)
Table 13. Global Rabies Virus Monoclonal Antibody Sale by Application (2019-2024) & (K Units)
Table 14. Global Rabies Virus Monoclonal Antibody Sale Market Share by Application (2019-2024)
Table 15. Global Rabies Virus Monoclonal Antibody Revenue by Application (2019-2024) & ($ million)
Table 16. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Application (2019-2024)
Table 17. Global Rabies Virus Monoclonal Antibody Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Rabies Virus Monoclonal Antibody Sales by Company (2019-2024) & (K Units)
Table 19. Global Rabies Virus Monoclonal Antibody Sales Market Share by Company (2019-2024)
Table 20. Global Rabies Virus Monoclonal Antibody Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Company (2019-2024)
Table 22. Global Rabies Virus Monoclonal Antibody Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Rabies Virus Monoclonal Antibody Producing Area Distribution and Sales Area
Table 24. Players Rabies Virus Monoclonal Antibody Products Offered
Table 25. Rabies Virus Monoclonal Antibody Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Rabies Virus Monoclonal Antibody Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Rabies Virus Monoclonal Antibody Sales Market Share Geographic Region (2019-2024)
Table 30. Global Rabies Virus Monoclonal Antibody Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Rabies Virus Monoclonal Antibody Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Rabies Virus Monoclonal Antibody Sales Market Share by Country/Region (2019-2024)
Table 34. Global Rabies Virus Monoclonal Antibody Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Rabies Virus Monoclonal Antibody Sales by Country (2019-2024) & (K Units)
Table 37. Americas Rabies Virus Monoclonal Antibody Sales Market Share by Country (2019-2024)
Table 38. Americas Rabies Virus Monoclonal Antibody Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Rabies Virus Monoclonal Antibody Sales byType (2019-2024) & (K Units)
Table 40. Americas Rabies Virus Monoclonal Antibody Sales by Application (2019-2024) & (K Units)
Table 41. APAC Rabies Virus Monoclonal Antibody Sales by Region (2019-2024) & (K Units)
Table 42. APAC Rabies Virus Monoclonal Antibody Sales Market Share by Region (2019-2024)
Table 43. APAC Rabies Virus Monoclonal Antibody Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Rabies Virus Monoclonal Antibody Sales byType (2019-2024) & (K Units)
Table 45. APAC Rabies Virus Monoclonal Antibody Sales by Application (2019-2024) & (K Units)
Table 46. Europe Rabies Virus Monoclonal Antibody Sales by Country (2019-2024) & (K Units)
Table 47. Europe Rabies Virus Monoclonal Antibody Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Rabies Virus Monoclonal Antibody Sales byType (2019-2024) & (K Units)
Table 49. Europe Rabies Virus Monoclonal Antibody Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Rabies Virus Monoclonal Antibody Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Rabies Virus Monoclonal Antibody Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Rabies Virus Monoclonal Antibody Sales byType (2019-2024) & (K Units)
Table 53. Middle East & Africa Rabies Virus Monoclonal Antibody Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Rabies Virus Monoclonal Antibody
Table 55. Key Market Challenges & Risks of Rabies Virus Monoclonal Antibody
Table 56. Key IndustryTrends of Rabies Virus Monoclonal Antibody
Table 57. Rabies Virus Monoclonal Antibody Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Rabies Virus Monoclonal Antibody Distributors List
Table 60. Rabies Virus Monoclonal Antibody Customer List
Table 61. Global Rabies Virus Monoclonal Antibody SalesForecast by Region (2025-2030) & (K Units)
Table 62. Global Rabies Virus Monoclonal Antibody RevenueForecast by Region (2025-2030) & ($ millions)
Table 63. Americas Rabies Virus Monoclonal Antibody SalesForecast by Country (2025-2030) & (K Units)
Table 64. Americas Rabies Virus Monoclonal Antibody Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 65. APAC Rabies Virus Monoclonal Antibody SalesForecast by Region (2025-2030) & (K Units)
Table 66. APAC Rabies Virus Monoclonal Antibody Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 67. Europe Rabies Virus Monoclonal Antibody SalesForecast by Country (2025-2030) & (K Units)
Table 68. Europe Rabies Virus Monoclonal Antibody RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Rabies Virus Monoclonal Antibody SalesForecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Rabies Virus Monoclonal Antibody RevenueForecast by Country (2025-2030) & ($ millions)
Table 71. Global Rabies Virus Monoclonal Antibody SalesForecast byType (2025-2030) & (K Units)
Table 72. Global Rabies Virus Monoclonal Antibody RevenueForecast byType (2025-2030) & ($ millions)
Table 73. Global Rabies Virus Monoclonal Antibody SalesForecast by Application (2025-2030) & (K Units)
Table 74. Global Rabies Virus Monoclonal Antibody RevenueForecast by Application (2025-2030) & ($ millions)
Table 75. Serum Institute of India Basic Information, Rabies Virus Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 76. Serum Institute of India Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
Table 77. Serum Institute of India Rabies Virus Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Serum Institute of India Main Business
Table 79. Serum Institute of India Latest Developments
Table 80. Zydus Lifesciences Basic Information, Rabies Virus Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 81. Zydus Lifesciences Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
Table 82. Zydus Lifesciences Rabies Virus Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Zydus Lifesciences Main Business
Table 84. Zydus Lifesciences Latest Developments
Table 85. North China Pharmaceutical Basic Information, Rabies Virus Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 86. North China Pharmaceutical Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
Table 87. North China Pharmaceutical Rabies Virus Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. North China Pharmaceutical Main Business
Table 89. North China Pharmaceutical Latest Developments
Table 90. Xingmeng Biopharmaceuticals (Suzhou) Basic Information, Rabies Virus Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 91. Xingmeng Biopharmaceuticals (Suzhou) Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
Table 92. Xingmeng Biopharmaceuticals (Suzhou) Rabies Virus Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Xingmeng Biopharmaceuticals (Suzhou) Main Business
Table 94. Xingmeng Biopharmaceuticals (Suzhou) Latest Developments
LIST OFFIGURES
Figure 1. Picture of Rabies Virus Monoclonal Antibody
Figure 2. Rabies Virus Monoclonal Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rabies Virus Monoclonal Antibody Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Rabies Virus Monoclonal Antibody Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Rabies Virus Monoclonal Antibody Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Rabies Virus Monoclonal Antibody Sales Market Share by Country/Region (2023)
Figure 10. Rabies Virus Monoclonal Antibody Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 100IU per Vial
Figure 12. Product Picture of 200IU per Vial
Figure 13. Product Picture of 250IU per Vial
Figure 14. Product Picture of 600IU per Vial
Figure 15. Product Picture of 1500IU per Vial
Figure 16. Global Rabies Virus Monoclonal Antibody Sales Market Share byType in 2023
Figure 17. Global Rabies Virus Monoclonal Antibody Revenue Market Share byType (2019-2024)
Figure 18. Rabies Virus Monoclonal Antibody Consumed in Category II Exposure
Figure 19. Global Rabies Virus Monoclonal Antibody Market: Category II Exposure (2019-2024) & (K Units)
Figure 20. Rabies Virus Monoclonal Antibody Consumed in Category III Exposure
Figure 21. Global Rabies Virus Monoclonal Antibody Market: Category III Exposure (2019-2024) & (K Units)
Figure 22. Global Rabies Virus Monoclonal Antibody Sale Market Share by Application (2023)
Figure 23. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Application in 2023
Figure 24. Rabies Virus Monoclonal Antibody Sales by Company in 2023 (K Units)
Figure 25. Global Rabies Virus Monoclonal Antibody Sales Market Share by Company in 2023
Figure 26. Rabies Virus Monoclonal Antibody Revenue by Company in 2023 ($ millions)
Figure 27. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Company in 2023
Figure 28. Global Rabies Virus Monoclonal Antibody Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Rabies Virus Monoclonal Antibody Sales 2019-2024 (K Units)
Figure 31. Americas Rabies Virus Monoclonal Antibody Revenue 2019-2024 ($ millions)
Figure 32. APAC Rabies Virus Monoclonal Antibody Sales 2019-2024 (K Units)
Figure 33. APAC Rabies Virus Monoclonal Antibody Revenue 2019-2024 ($ millions)
Figure 34. Europe Rabies Virus Monoclonal Antibody Sales 2019-2024 (K Units)
Figure 35. Europe Rabies Virus Monoclonal Antibody Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Rabies Virus Monoclonal Antibody Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Rabies Virus Monoclonal Antibody Revenue 2019-2024 ($ millions)
Figure 38. Americas Rabies Virus Monoclonal Antibody Sales Market Share by Country in 2023
Figure 39. Americas Rabies Virus Monoclonal Antibody Revenue Market Share by Country (2019-2024)
Figure 40. Americas Rabies Virus Monoclonal Antibody Sales Market Share byType (2019-2024)
Figure 41. Americas Rabies Virus Monoclonal Antibody Sales Market Share by Application (2019-2024)
Figure 42. United States Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Rabies Virus Monoclonal Antibody Sales Market Share by Region in 2023
Figure 47. APAC Rabies Virus Monoclonal Antibody Revenue Market Share by Region (2019-2024)
Figure 48. APAC Rabies Virus Monoclonal Antibody Sales Market Share byType (2019-2024)
Figure 49. APAC Rabies Virus Monoclonal Antibody Sales Market Share by Application (2019-2024)
Figure 50. China Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 54. India Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 56. ChinaTaiwan Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Rabies Virus Monoclonal Antibody Sales Market Share by Country in 2023
Figure 58. Europe Rabies Virus Monoclonal Antibody Revenue Market Share by Country (2019-2024)
Figure 59. Europe Rabies Virus Monoclonal Antibody Sales Market Share byType (2019-2024)
Figure 60. Europe Rabies Virus Monoclonal Antibody Sales Market Share by Application (2019-2024)
Figure 61. Germany Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 62.France Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Rabies Virus Monoclonal Antibody Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Rabies Virus Monoclonal Antibody Sales Market Share byType (2019-2024)
Figure 68. Middle East & Africa Rabies Virus Monoclonal Antibody Sales Market Share by Application (2019-2024)
Figure 69. Egypt Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 72.Turkey Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Rabies Virus Monoclonal Antibody in 2023
Figure 75. Manufacturing Process Analysis of Rabies Virus Monoclonal Antibody
Figure 76. Industry Chain Structure of Rabies Virus Monoclonal Antibody
Figure 77. Channels of Distribution
Figure 78. Global Rabies Virus Monoclonal Antibody Sales MarketForecast by Region (2025-2030)
Figure 79. Global Rabies Virus Monoclonal Antibody Revenue Market ShareForecast by Region (2025-2030)
Figure 80. Global Rabies Virus Monoclonal Antibody Sales Market ShareForecast byType (2025-2030)
Figure 81. Global Rabies Virus Monoclonal Antibody Revenue Market ShareForecast byType (2025-2030)
Figure 82. Global Rabies Virus Monoclonal Antibody Sales Market ShareForecast by Application (2025-2030)
Figure 83. Global Rabies Virus Monoclonal Antibody Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rabies Virus Monoclonal Antibody Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Rabies Virus Monoclonal Antibody by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Rabies Virus Monoclonal Antibody by Country/Region, 2019, 2023 & 2030
2.2 Rabies Virus Monoclonal Antibody Segment by Type
2.2.1 100IU per Vial
2.2.2 200IU per Vial
2.2.3 250IU per Vial
2.2.4 600IU per Vial
2.2.5 1500IU per Vial
2.3 Rabies Virus Monoclonal Antibody Sales by Type
2.3.1 Global Rabies Virus Monoclonal Antibody Sales Market Share by Type (2019-2024)
2.3.2 Global Rabies Virus Monoclonal Antibody Revenue and Market Share by Type (2019-2024)
2.3.3 Global Rabies Virus Monoclonal Antibody Sale Price by Type (2019-2024)
2.4 Rabies Virus Monoclonal Antibody Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Rabies Virus Monoclonal Antibody Sales by Application
2.5.1 Global Rabies Virus Monoclonal Antibody Sale Market Share by Application (2019-2024)
2.5.2 Global Rabies Virus Monoclonal Antibody Revenue and Market Share by Application (2019-2024)
2.5.3 Global Rabies Virus Monoclonal Antibody Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Rabies Virus Monoclonal Antibody Breakdown Data by Company
3.1.1 Global Rabies Virus Monoclonal Antibody Annual Sales by Company (2019-2024)
3.1.2 Global Rabies Virus Monoclonal Antibody Sales Market Share by Company (2019-2024)
3.2 Global Rabies Virus Monoclonal Antibody Annual Revenue by Company (2019-2024)
3.2.1 Global Rabies Virus Monoclonal Antibody Revenue by Company (2019-2024)
3.2.2 Global Rabies Virus Monoclonal Antibody Revenue Market Share by Company (2019-2024)
3.3 Global Rabies Virus Monoclonal Antibody Sale Price by Company
3.4 Key Manufacturers Rabies Virus Monoclonal Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rabies Virus Monoclonal Antibody Product Location Distribution
3.4.2 Players Rabies Virus Monoclonal Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RABIES VIRUS MONOCLONAL ANTIBODY BY GEOGRAPHIC REGION
4.1 World Historic Rabies Virus Monoclonal Antibody Market Size by Geographic Region (2019-2024)
4.1.1 Global Rabies Virus Monoclonal Antibody Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Rabies Virus Monoclonal Antibody Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Rabies Virus Monoclonal Antibody Market Size by Country/Region (2019-2024)
4.2.1 Global Rabies Virus Monoclonal Antibody Annual Sales by Country/Region (2019-2024)
4.2.2 Global Rabies Virus Monoclonal Antibody Annual Revenue by Country/Region (2019-2024)
4.3 Americas Rabies Virus Monoclonal Antibody Sales Growth
4.4 APAC Rabies Virus Monoclonal Antibody Sales Growth
4.5 Europe Rabies Virus Monoclonal Antibody Sales Growth
4.6 Middle East & Africa Rabies Virus Monoclonal Antibody Sales Growth
5 AMERICAS
5.1 Americas Rabies Virus Monoclonal Antibody Sales by Country
5.1.1 Americas Rabies Virus Monoclonal Antibody Sales by Country (2019-2024)
5.1.2 Americas Rabies Virus Monoclonal Antibody Revenue by Country (2019-2024)
5.2 Americas Rabies Virus Monoclonal Antibody Sales by Type (2019-2024)
5.3 Americas Rabies Virus Monoclonal Antibody Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rabies Virus Monoclonal Antibody Sales by Region
6.1.1 APAC Rabies Virus Monoclonal Antibody Sales by Region (2019-2024)
6.1.2 APAC Rabies Virus Monoclonal Antibody Revenue by Region (2019-2024)
6.2 APAC Rabies Virus Monoclonal Antibody Sales by Type (2019-2024)
6.3 APAC Rabies Virus Monoclonal Antibody Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rabies Virus Monoclonal Antibody by Country
7.1.1 Europe Rabies Virus Monoclonal Antibody Sales by Country (2019-2024)
7.1.2 Europe Rabies Virus Monoclonal Antibody Revenue by Country (2019-2024)
7.2 Europe Rabies Virus Monoclonal Antibody Sales by Type (2019-2024)
7.3 Europe Rabies Virus Monoclonal Antibody Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rabies Virus Monoclonal Antibody by Country
8.1.1 Middle East & Africa Rabies Virus Monoclonal Antibody Sales by Country (2019-2024)
8.1.2 Middle East & Africa Rabies Virus Monoclonal Antibody Revenue by Country (2019-2024)
8.2 Middle East & Africa Rabies Virus Monoclonal Antibody Sales by Type (2019-2024)
8.3 Middle East & Africa Rabies Virus Monoclonal Antibody Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rabies Virus Monoclonal Antibody
10.3 Manufacturing Process Analysis of Rabies Virus Monoclonal Antibody
10.4 Industry Chain Structure of Rabies Virus Monoclonal Antibody
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rabies Virus Monoclonal Antibody Distributors
11.3 Rabies Virus Monoclonal Antibody Customer
12 WORLD FORECAST REVIEW FOR RABIES VIRUS MONOCLONAL ANTIBODY BY GEOGRAPHIC REGION
12.1 Global Rabies Virus Monoclonal Antibody Market Size Forecast by Region
12.1.1 Global Rabies Virus Monoclonal Antibody Forecast by Region (2025-2030)
12.1.2 Global Rabies Virus Monoclonal Antibody Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Rabies Virus Monoclonal Antibody Forecast by Type (2025-2030)
12.7 Global Rabies Virus Monoclonal Antibody Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Serum Institute of India
13.1.1 Serum Institute of India Company Information
13.1.2 Serum Institute of India Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
13.1.3 Serum Institute of India Rabies Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Serum Institute of India Main Business Overview
13.1.5 Serum Institute of India Latest Developments
13.2 Zydus Lifesciences
13.2.1 Zydus Lifesciences Company Information
13.2.2 Zydus Lifesciences Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
13.2.3 Zydus Lifesciences Rabies Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Zydus Lifesciences Main Business Overview
13.2.5 Zydus Lifesciences Latest Developments
13.3 North China Pharmaceutical
13.3.1 North China Pharmaceutical Company Information
13.3.2 North China Pharmaceutical Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
13.3.3 North China Pharmaceutical Rabies Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 North China Pharmaceutical Main Business Overview
13.3.5 North China Pharmaceutical Latest Developments
13.4 Xingmeng Biopharmaceuticals (Suzhou)
13.4.1 Xingmeng Biopharmaceuticals (Suzhou) Company Information
13.4.2 Xingmeng Biopharmaceuticals (Suzhou) Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
13.4.3 Xingmeng Biopharmaceuticals (Suzhou) Rabies Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Xingmeng Biopharmaceuticals (Suzhou) Main Business Overview
13.4.5 Xingmeng Biopharmaceuticals (Suzhou) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Rabies Virus Monoclonal Antibody Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Rabies Virus Monoclonal Antibody Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 100IU per Vial
Table 4. Major Players of 200IU per Vial
Table 5. Major Players of 250IU per Vial
Table 6. Major Players of 600IU per Vial
Table 7. Major Players of 1500IU per Vial
Table 8. Global Rabies Virus Monoclonal Antibody Sales byType (2019-2024) & (K Units)
Table 9. Global Rabies Virus Monoclonal Antibody Sales Market Share byType (2019-2024)
Table 10. Global Rabies Virus Monoclonal Antibody Revenue byType (2019-2024) & ($ million)
Table 11. Global Rabies Virus Monoclonal Antibody Revenue Market Share byType (2019-2024)
Table 12. Global Rabies Virus Monoclonal Antibody Sale Price byType (2019-2024) & (US$/Unit)
Table 13. Global Rabies Virus Monoclonal Antibody Sale by Application (2019-2024) & (K Units)
Table 14. Global Rabies Virus Monoclonal Antibody Sale Market Share by Application (2019-2024)
Table 15. Global Rabies Virus Monoclonal Antibody Revenue by Application (2019-2024) & ($ million)
Table 16. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Application (2019-2024)
Table 17. Global Rabies Virus Monoclonal Antibody Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Rabies Virus Monoclonal Antibody Sales by Company (2019-2024) & (K Units)
Table 19. Global Rabies Virus Monoclonal Antibody Sales Market Share by Company (2019-2024)
Table 20. Global Rabies Virus Monoclonal Antibody Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Company (2019-2024)
Table 22. Global Rabies Virus Monoclonal Antibody Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Rabies Virus Monoclonal Antibody Producing Area Distribution and Sales Area
Table 24. Players Rabies Virus Monoclonal Antibody Products Offered
Table 25. Rabies Virus Monoclonal Antibody Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Rabies Virus Monoclonal Antibody Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Rabies Virus Monoclonal Antibody Sales Market Share Geographic Region (2019-2024)
Table 30. Global Rabies Virus Monoclonal Antibody Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Rabies Virus Monoclonal Antibody Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Rabies Virus Monoclonal Antibody Sales Market Share by Country/Region (2019-2024)
Table 34. Global Rabies Virus Monoclonal Antibody Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Rabies Virus Monoclonal Antibody Sales by Country (2019-2024) & (K Units)
Table 37. Americas Rabies Virus Monoclonal Antibody Sales Market Share by Country (2019-2024)
Table 38. Americas Rabies Virus Monoclonal Antibody Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Rabies Virus Monoclonal Antibody Sales byType (2019-2024) & (K Units)
Table 40. Americas Rabies Virus Monoclonal Antibody Sales by Application (2019-2024) & (K Units)
Table 41. APAC Rabies Virus Monoclonal Antibody Sales by Region (2019-2024) & (K Units)
Table 42. APAC Rabies Virus Monoclonal Antibody Sales Market Share by Region (2019-2024)
Table 43. APAC Rabies Virus Monoclonal Antibody Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Rabies Virus Monoclonal Antibody Sales byType (2019-2024) & (K Units)
Table 45. APAC Rabies Virus Monoclonal Antibody Sales by Application (2019-2024) & (K Units)
Table 46. Europe Rabies Virus Monoclonal Antibody Sales by Country (2019-2024) & (K Units)
Table 47. Europe Rabies Virus Monoclonal Antibody Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Rabies Virus Monoclonal Antibody Sales byType (2019-2024) & (K Units)
Table 49. Europe Rabies Virus Monoclonal Antibody Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Rabies Virus Monoclonal Antibody Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Rabies Virus Monoclonal Antibody Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Rabies Virus Monoclonal Antibody Sales byType (2019-2024) & (K Units)
Table 53. Middle East & Africa Rabies Virus Monoclonal Antibody Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Rabies Virus Monoclonal Antibody
Table 55. Key Market Challenges & Risks of Rabies Virus Monoclonal Antibody
Table 56. Key IndustryTrends of Rabies Virus Monoclonal Antibody
Table 57. Rabies Virus Monoclonal Antibody Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Rabies Virus Monoclonal Antibody Distributors List
Table 60. Rabies Virus Monoclonal Antibody Customer List
Table 61. Global Rabies Virus Monoclonal Antibody SalesForecast by Region (2025-2030) & (K Units)
Table 62. Global Rabies Virus Monoclonal Antibody RevenueForecast by Region (2025-2030) & ($ millions)
Table 63. Americas Rabies Virus Monoclonal Antibody SalesForecast by Country (2025-2030) & (K Units)
Table 64. Americas Rabies Virus Monoclonal Antibody Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 65. APAC Rabies Virus Monoclonal Antibody SalesForecast by Region (2025-2030) & (K Units)
Table 66. APAC Rabies Virus Monoclonal Antibody Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 67. Europe Rabies Virus Monoclonal Antibody SalesForecast by Country (2025-2030) & (K Units)
Table 68. Europe Rabies Virus Monoclonal Antibody RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Rabies Virus Monoclonal Antibody SalesForecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Rabies Virus Monoclonal Antibody RevenueForecast by Country (2025-2030) & ($ millions)
Table 71. Global Rabies Virus Monoclonal Antibody SalesForecast byType (2025-2030) & (K Units)
Table 72. Global Rabies Virus Monoclonal Antibody RevenueForecast byType (2025-2030) & ($ millions)
Table 73. Global Rabies Virus Monoclonal Antibody SalesForecast by Application (2025-2030) & (K Units)
Table 74. Global Rabies Virus Monoclonal Antibody RevenueForecast by Application (2025-2030) & ($ millions)
Table 75. Serum Institute of India Basic Information, Rabies Virus Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 76. Serum Institute of India Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
Table 77. Serum Institute of India Rabies Virus Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Serum Institute of India Main Business
Table 79. Serum Institute of India Latest Developments
Table 80. Zydus Lifesciences Basic Information, Rabies Virus Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 81. Zydus Lifesciences Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
Table 82. Zydus Lifesciences Rabies Virus Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Zydus Lifesciences Main Business
Table 84. Zydus Lifesciences Latest Developments
Table 85. North China Pharmaceutical Basic Information, Rabies Virus Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 86. North China Pharmaceutical Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
Table 87. North China Pharmaceutical Rabies Virus Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. North China Pharmaceutical Main Business
Table 89. North China Pharmaceutical Latest Developments
Table 90. Xingmeng Biopharmaceuticals (Suzhou) Basic Information, Rabies Virus Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 91. Xingmeng Biopharmaceuticals (Suzhou) Rabies Virus Monoclonal Antibody Product Portfolios and Specifications
Table 92. Xingmeng Biopharmaceuticals (Suzhou) Rabies Virus Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Xingmeng Biopharmaceuticals (Suzhou) Main Business
Table 94. Xingmeng Biopharmaceuticals (Suzhou) Latest Developments
LIST OFFIGURES
Figure 1. Picture of Rabies Virus Monoclonal Antibody
Figure 2. Rabies Virus Monoclonal Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rabies Virus Monoclonal Antibody Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Rabies Virus Monoclonal Antibody Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Rabies Virus Monoclonal Antibody Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Rabies Virus Monoclonal Antibody Sales Market Share by Country/Region (2023)
Figure 10. Rabies Virus Monoclonal Antibody Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 100IU per Vial
Figure 12. Product Picture of 200IU per Vial
Figure 13. Product Picture of 250IU per Vial
Figure 14. Product Picture of 600IU per Vial
Figure 15. Product Picture of 1500IU per Vial
Figure 16. Global Rabies Virus Monoclonal Antibody Sales Market Share byType in 2023
Figure 17. Global Rabies Virus Monoclonal Antibody Revenue Market Share byType (2019-2024)
Figure 18. Rabies Virus Monoclonal Antibody Consumed in Category II Exposure
Figure 19. Global Rabies Virus Monoclonal Antibody Market: Category II Exposure (2019-2024) & (K Units)
Figure 20. Rabies Virus Monoclonal Antibody Consumed in Category III Exposure
Figure 21. Global Rabies Virus Monoclonal Antibody Market: Category III Exposure (2019-2024) & (K Units)
Figure 22. Global Rabies Virus Monoclonal Antibody Sale Market Share by Application (2023)
Figure 23. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Application in 2023
Figure 24. Rabies Virus Monoclonal Antibody Sales by Company in 2023 (K Units)
Figure 25. Global Rabies Virus Monoclonal Antibody Sales Market Share by Company in 2023
Figure 26. Rabies Virus Monoclonal Antibody Revenue by Company in 2023 ($ millions)
Figure 27. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Company in 2023
Figure 28. Global Rabies Virus Monoclonal Antibody Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Rabies Virus Monoclonal Antibody Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Rabies Virus Monoclonal Antibody Sales 2019-2024 (K Units)
Figure 31. Americas Rabies Virus Monoclonal Antibody Revenue 2019-2024 ($ millions)
Figure 32. APAC Rabies Virus Monoclonal Antibody Sales 2019-2024 (K Units)
Figure 33. APAC Rabies Virus Monoclonal Antibody Revenue 2019-2024 ($ millions)
Figure 34. Europe Rabies Virus Monoclonal Antibody Sales 2019-2024 (K Units)
Figure 35. Europe Rabies Virus Monoclonal Antibody Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Rabies Virus Monoclonal Antibody Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Rabies Virus Monoclonal Antibody Revenue 2019-2024 ($ millions)
Figure 38. Americas Rabies Virus Monoclonal Antibody Sales Market Share by Country in 2023
Figure 39. Americas Rabies Virus Monoclonal Antibody Revenue Market Share by Country (2019-2024)
Figure 40. Americas Rabies Virus Monoclonal Antibody Sales Market Share byType (2019-2024)
Figure 41. Americas Rabies Virus Monoclonal Antibody Sales Market Share by Application (2019-2024)
Figure 42. United States Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Rabies Virus Monoclonal Antibody Sales Market Share by Region in 2023
Figure 47. APAC Rabies Virus Monoclonal Antibody Revenue Market Share by Region (2019-2024)
Figure 48. APAC Rabies Virus Monoclonal Antibody Sales Market Share byType (2019-2024)
Figure 49. APAC Rabies Virus Monoclonal Antibody Sales Market Share by Application (2019-2024)
Figure 50. China Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 54. India Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 56. ChinaTaiwan Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Rabies Virus Monoclonal Antibody Sales Market Share by Country in 2023
Figure 58. Europe Rabies Virus Monoclonal Antibody Revenue Market Share by Country (2019-2024)
Figure 59. Europe Rabies Virus Monoclonal Antibody Sales Market Share byType (2019-2024)
Figure 60. Europe Rabies Virus Monoclonal Antibody Sales Market Share by Application (2019-2024)
Figure 61. Germany Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 62.France Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Rabies Virus Monoclonal Antibody Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Rabies Virus Monoclonal Antibody Sales Market Share byType (2019-2024)
Figure 68. Middle East & Africa Rabies Virus Monoclonal Antibody Sales Market Share by Application (2019-2024)
Figure 69. Egypt Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 72.Turkey Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Rabies Virus Monoclonal Antibody Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Rabies Virus Monoclonal Antibody in 2023
Figure 75. Manufacturing Process Analysis of Rabies Virus Monoclonal Antibody
Figure 76. Industry Chain Structure of Rabies Virus Monoclonal Antibody
Figure 77. Channels of Distribution
Figure 78. Global Rabies Virus Monoclonal Antibody Sales MarketForecast by Region (2025-2030)
Figure 79. Global Rabies Virus Monoclonal Antibody Revenue Market ShareForecast by Region (2025-2030)
Figure 80. Global Rabies Virus Monoclonal Antibody Sales Market ShareForecast byType (2025-2030)
Figure 81. Global Rabies Virus Monoclonal Antibody Revenue Market ShareForecast byType (2025-2030)
Figure 82. Global Rabies Virus Monoclonal Antibody Sales Market ShareForecast by Application (2025-2030)
Figure 83. Global Rabies Virus Monoclonal Antibody Revenue Market ShareForecast by Application (2025-2030)
